V-Wave is a privately held medical device company that was established in 2009 and is focused on developing innovative treatment options for people living with heart failure and cardiovascular disease. The company was built on a foundation of science, engineering and medicine and has decades of experience in these fields. V-Wave’s lead program is the investigational V-Wave® Ventura® Interatrial Shunt, which has Breakthrough Device Designation from the U.S. Food and Drug Administration and is designed to offer a safe, minimally invasive approach to treat heart failure. The company has offices in Israel and the U.S..
Additional Info
ACC.24 Learning Pathways? (select all that apply)
Heart Failure and CardiomyopathiesFirst time Exhibitor?
Yes